Cardiovascular calcification and disease in adult hemodialysis patients

Dialysis and Transplantation

Volumn 31, Issue 6, 2002, Pages 393-400

  Raggi, Paolo ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CARBONATE; CALCIUM ION; CITRATE CALCIUM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PHOSPHATE BINDING AGENT; PHOSPHORUS; SEVELAMER; STATINE DERIVATIVE;

AORTA; ATHEROSCLEROSIS; CALCIFICATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC PROCEDURE; DISEASE SEVERITY; ELECTRON BEAM TOMOGRAPHY; HEART VALVE; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MINERAL METABOLISM; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; REVIEW; RISK FACTOR; TREATMENT OUTCOME;

EID: 0036259622     PISSN: 00902934     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (34)

1. Clinical epidemiology of cardiovascular disease in chronic renal disease
2. Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: The HOPE randomized trial
3. The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions
4. Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: Recommendations for a change in management
5. Prevalence and clinical consequences of elevated Ca x P product in hemodialysis patients
6. United States renal data system. Chapter IV. Medication use among dialysis patients in the DMMS
7. Electron beam computed tomography in the evaluation of cardiac calcification in chronic dialysis patients
8. Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: A national study
9. Cardiac valve calcification in haemodialysis patients: Role of calcium-phosphate metabolism
10. Myocardial calcification and cardiac dysfunction in chronic renal failure
11. Factors associated with calcification of the abdominal aorta in hemodialysis patients
12. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis
13. Cardiac calcification in adult hemodialysis patients: A link between end-stage renal disease and cardiovascular disease?
14. Quantification of coronary artery calcium using ultrafast computed tomography
15. Identification of patients at increased risk of first unheralded acute myocardial infarction by electron-beam computed tomography
16. Consequences of hyperphosphatemia and elevated levels of the calcium-phosphorus product in dialysis patients
17. Evidence for abnormal calcium homeostasis in patients with adynamic bone disease
18. Phosphorus restriction and control of coronary calcification as assessed by electron beam tomography
19. Phosphate regulation of vascular smooth muscle cell calcification
20. 4 product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients
21. Noninvasive definition of anatomic coronary artery disease by ultrafast computed tomographic scanning: A quantitative pathologic comparison study
22. Coronary artery disease: Prediction with in vitro electron beam CT
23. Arterial calcification and not lumen stenosis is highly correlated with atherosclerotic plaque burden in humans: A histologic study of 723 coronary artery segments using nondecalcifying methodology
24. Prediction of coronary events with electron beam computed tomography
25. Coronary artery calcium evaluation by electron beam computed tomography and its relation to new cardiovascular events
26. The diagnostic and prognostic significance of coronary artery calcification: A report of 800 cases
27. Coronary artery calcium area by electron-beam computed tomography and coronary atherosclerotic plaque area: A histopathologic correlative study
28. Use of electron beam tomography data to develop models for prediction of hard coronary events
29. High coronary artery calcium scores pose an extremely elevated risk for hard events
30. Coronary artery calcifications in children and young adults treated with renal replacement therapy
31. Are we mismanaging calcium and phosphate metabolism in renal failure?
32. A comparison of the calcium-free phosphate binder sevelamer hydrochloride with calcium acetate in the treatment of hyperphosphatemia in hemodialysis patients
33. Long-term effects of sevelamer hydrochloride on the calcium x phosphate product and lipid profile of haemodialysis patients
34. HMG-CoA reductase inhibitors are associated with reduced mortality in ESRD patients